These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10572662)

  • 21. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.
    Abbate I; Cappiello G; Longo R; Ursitti A; Spanò A; Calcaterra S; Dianzani F; Antinori A; Capobianchi MR
    Infect Genet Evol; 2005 Apr; 5(3):247-53. PubMed ID: 15737916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global epidemiology of HIV.
    McCutchan FE
    J Med Virol; 2006; 78 Suppl 1():S7-S12. PubMed ID: 16622870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS.
    AIDS; 1997 Dec; 11(15):17-36. PubMed ID: 9412719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging issues in AIDS: variant strains of human immunodeficiency virus and its subtypes.
    Paul SM; Cross H; Costa SJ; Pierce M; Pizzuti W; Morgan DH; Ziskin LZ
    MLO Med Lab Obs; 1998 Feb; 30(2):32-6. PubMed ID: 10179126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation within human immunodeficiency viruses generates rapid changes in tropism, virulence, and transmission.
    Essex M; Soto-Ramirez LE; Renjifo E; Wang WK; Lee TH
    Leukemia; 1997 Apr; 11 Suppl 3():93-4. PubMed ID: 9209309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV-1 genetic diversity: mechanism and its biological implication].
    Takebe Y
    Uirusu; 2001 Dec; 51(2):123-34. PubMed ID: 11977752
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of gag gene subtypes of HIV-1 variants isolated in Russia by comparative assessment of heteroduplex electrophoretic mobility].
    Kazennova EV; Bobkov AF; Selimova LM; Khanina TA; Pokrovskiĭ VV; Heyndrickx L; Van der Groen G
    Vopr Virusol; 2001; 46(3):12-6. PubMed ID: 11450137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype.
    Paraskevis D; Magiorkinis E; Magiorkinis G; Anastassopoulou C; Lazanas M; Chrysos G; Vandamme AM; Hatzakis A
    J Gen Virol; 2001 Oct; 82(Pt 10):2509-2514. PubMed ID: 11562543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of the HIV pandemic.
    Essex M
    J Hum Virol; 1998; 1(7):427-9. PubMed ID: 10195263
    [No Abstract]   [Full Text] [Related]  

  • 31. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.
    Ariën KK; Abraha A; Quiñones-Mateu ME; Kestens L; Vanham G; Arts EJ
    J Virol; 2005 Jul; 79(14):8979-90. PubMed ID: 15994792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.
    Liner KJ; Hall CD; Robertson KR
    J Neurovirol; 2007 Aug; 13(4):291-304. PubMed ID: 17849313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV global pandemic: the development and emerging implication.
    Scully C
    Oral Dis; 1997 May; 3 Suppl 1():S1-6. PubMed ID: 9456648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HIV-1 diversity: a tool for studying the pandemic].
    Pinto ME; Struchiner CJ
    Cad Saude Publica; 2006 Mar; 22(3):473-84. PubMed ID: 16583091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different epidemic potentials of the HIV-1B and C subtypes.
    Salemi M; de Oliveira T; Soares MA; Pybus O; Dumans AT; Vandamme AM; Tanuri A; Cassol S; Fitch WM
    J Mol Evol; 2005 May; 60(5):598-605. PubMed ID: 15983869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Travel and the spread of HIV-1 genetic variants.
    Perrin L; Kaiser L; Yerly S
    Lancet Infect Dis; 2003 Jan; 3(1):22-7. PubMed ID: 12505029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 group O infection in Cameroon, 1986 to 1998.
    Ayouba A; Mauclère P; Martin PM; Cunin P; Mfoupouendoun J; Njinku B; Souquières S; Simon F
    Emerg Infect Dis; 2001; 7(3):466-7. PubMed ID: 11384531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is AIDS in Africa a distinct disease?
    Cohen J
    Science; 2000 Jun; 288(5474):2153-5. PubMed ID: 10896593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using genomic signatures for HIV-1 sub-typing.
    Pandit A; Sinha S
    BMC Bioinformatics; 2010 Jan; 11 Suppl 1(Suppl 1):S26. PubMed ID: 20122198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group O human immunodeficiency virus-1 infections.
    Jaffe HW; Schochetman G
    Infect Dis Clin North Am; 1998 Mar; 12(1):39-46. PubMed ID: 9494828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.